These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 12905010

  • 1. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
    Nonn M, Schinz M, Zumbach K, Pawlita M, Schneider A, Dürst M, Kaufmann AM.
    J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
    [Abstract] [Full Text] [Related]

  • 2. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.
    Santin AD, Bellone S, Palmieri M, Bossini B, Roman JJ, Cannon MJ, Bignotti E, Canè S, Pecorelli S.
    Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
    Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
    [Abstract] [Full Text] [Related]

  • 7. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD, Bellone S, Palmieri M, Ravaggi A, Romani C, Tassi R, Roman JJ, Burnett A, Pecorelli S, Cannon MJ.
    Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
    [Abstract] [Full Text] [Related]

  • 8. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ, Kenter GG, Piersma SJ, Vloon AP, Löwik MJ, Berends-van der Meer DM, Drijfhout JW, Valentijn AR, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, Melief CJ, van der Burg SH.
    Clin Cancer Res; 2008 Jan 01; 14(1):178-87. PubMed ID: 18172269
    [Abstract] [Full Text] [Related]

  • 9. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.
    Cheng WF, Lee CN, Su YN, Chang MC, Hsiao WC, Chen CA, Hsieh CY.
    Immunology; 2005 May 01; 115(1):136-49. PubMed ID: 15819706
    [Abstract] [Full Text] [Related]

  • 10. Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer.
    Schoell WM, Mirhashemi R, Liu B, Janicek MF, Podack ER, Penalver MA, Averette HE.
    Gynecol Oncol; 1999 Sep 01; 74(3):448-55. PubMed ID: 10479508
    [Abstract] [Full Text] [Related]

  • 11. Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.
    De Bruijn ML, Schuurhuis DH, Vierboom MP, Vermeulen H, de Cock KA, Ooms ME, Ressing ME, Toebes M, Franken KL, Drijfhout JW, Ottenhoff TH, Offringa R, Melief CJ.
    Cancer Res; 1998 Feb 15; 58(4):724-31. PubMed ID: 9485027
    [Abstract] [Full Text] [Related]

  • 12. HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination.
    Kaufmann AM, Nieland J, Schinz M, Nonn M, Gabelsberger J, Meissner H, Müller RT, Jochmus I, Gissmann L, Schneider A, Dürst M.
    Int J Cancer; 2001 Apr 15; 92(2):285-93. PubMed ID: 11291058
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.
    Nilges K, Höhn H, Pilch H, Neukirch C, Freitag K, Talbot PJ, Maeurer MJ.
    J Virol; 2003 May 15; 77(9):5464-74. PubMed ID: 12692247
    [Abstract] [Full Text] [Related]

  • 14. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity].
    Li J, Gao HQ, Zhao CL, Li LZ, Ji CY, Hou M, Plebaski M.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):932-6. PubMed ID: 15329282
    [Abstract] [Full Text] [Related]

  • 15. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.
    Chen XZ, Mao XH, Zhu KJ, Jin N, Ye J, Cen JP, Zhou Q, Cheng H.
    Arch Dermatol Res; 2010 Jan 02; 302(1):57-65. PubMed ID: 19578865
    [Abstract] [Full Text] [Related]

  • 16. Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
    Jochmus I, Osen W, Altmann A, Buck G, Hofmann B, Schneider A, Gissmann L, Rammensee HG.
    J Gen Virol; 1997 Jul 02; 78 ( Pt 7)():1689-95. PubMed ID: 9225046
    [Abstract] [Full Text] [Related]

  • 17. HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients.
    Valdespino V, Gorodezky C, Ortiz V, Kaufmann AM, Roman-Basaure E, Vazquez A, Berumen J.
    Gynecol Oncol; 2005 Jan 02; 96(1):92-102. PubMed ID: 15589586
    [Abstract] [Full Text] [Related]

  • 18. Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells.
    Cools N, Ponsaerts P, Lenjou M, Nijs G, Van Bockstaele DR, Van Tendeloo VF, Berneman ZN.
    Mol Cancer; 2006 Oct 26; 5():49. PubMed ID: 17067378
    [Abstract] [Full Text] [Related]

  • 19. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Jayaprabhu S, Pecorelli S, Parham GP, Cannon MJ.
    Clin Cancer Res; 2001 Mar 26; 7(3 Suppl):804s-810s. PubMed ID: 11300476
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K, Kisseljov F, Sacharova O, Shaichaev G, Semjonova L, Pavlova L, Pawlita M.
    Int J Cancer; 2000 Feb 01; 85(3):313-8. PubMed ID: 10652419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.